Dual antiplatelet therapy and antithrombotic treatment: Recommendations and controversies

Dual antiplatelet therapy is currently recommended for all patients with acute coronary syndromes, independent of whether they receive pharmacological treatment or undergo percutaneous coronary intervention. Antiplatelet agents are the cornerstone of pharmacological treatment in interventional cardi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cardiology journal 2009, Vol.16 (2), p.179
Hauptverfasser:	Bryniarski, Leszek, Pelc-Nowicka, Agnieszka, Zabojszcz, Michał, Mirek-Bryniarska, Ewa
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute Coronary Syndrome - drug therapy Angioplasty, Balloon, Coronary - adverse effects Atrial Fibrillation - drug therapy Cardiovascular Diseases - drug therapy Drug Therapy, Combination Fibrinolytic Agents - adverse effects Fibrinolytic Agents - therapeutic use Heart Valve Diseases - drug therapy Heart Valve Prosthesis Implantation - adverse effects Hemorrhage - chemically induced Humans Platelet Aggregation Inhibitors - adverse effects Platelet Aggregation Inhibitors - therapeutic use Practice Guidelines as Topic Risk Assessment Treatment Outcome Venous Thrombosis - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!